Company Registration No. 06347605 (England and Wales)
BEECHER PHARMA LTD
UNAUDITED ABBREVIATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2014
BEECHER PHARMA LTD
CONTENTS
Page
Abbreviated balance sheet
1
Notes to the abbreviated accounts
2 - 3
BEECHER PHARMA LTD
ABBREVIATED BALANCE SHEET
AS AT
31 DECEMBER 2014
31 December 2014
- 1 -
2014
2013
Notes
£
£
£
£
Fixed assets
Tangible assets
2
4,637
10,272
Investments
2
103,498
-
108,135
10,272
Current assets
Debtors
37,437
82,925
Cash at bank and in hand
940,822
81,409
978,259
164,334
Creditors: amounts falling due within one year
(353,932)
(24,402)
Net current assets
624,327
139,932
Total assets less current liabilities
732,462
150,204
Provisions for liabilities
(775)
-
731,687
150,204
Capital and reserves
Called up share capital
3
1,000
1,000
Profit and loss account
730,687
149,204
Shareholders' funds
731,687
150,204
For the financial year ended 31 December 2014 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
Approved by the Board for issue on 21 July 2015
Ms T F Beecher Jones
Director
Company Registration No. 06347605
BEECHER PHARMA LTD
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 DECEMBER 2014
- 2 -
1
Accounting policies
1.1
Accounting convention
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).
1.2
Compliance with accounting standards
The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).
1.3
Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.
1.4
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Computer equipment
33% on cost.
Motor vehicles
25% on cost.
1.5
Investments
Fixed asset investments are stated at cost less any provision for impairment.
1.6
Pensions
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.
1.7
Deferred taxation
Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.
1.8
Foreign currency translation
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.
BEECHER PHARMA LTD
NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2014
- 3 -
2
Fixed assets
Tangible assets
Investments
Total
£
£
£
Cost
At 1 January 2014
25,002
-
25,002
Additions
4,458
181,023
185,481
Disposals
(17,318)
(77,525)
(94,843)
At 31 December 2014
12,142
103,498
115,640
Depreciation
At 1 January 2014
14,730
-
14,730
On disposals
(7,937)
-
(7,937)
Charge for the year
712
-
712
At 31 December 2014
7,505
-
7,505
Net book value
At 31 December 2014
4,637
103,498
108,135
At 31 December 2013
10,272
-
10,272
3
Share capital
2014
2013
£
£
Allotted, called up and fully paid
1,000 Ordinary Shares of £1 each
1,000
1,000